Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Genentech
(https://gene.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Genentech (https://gene.com)
Genentech
Breakthrough science. One moment, one day, one person at a time.
NAV_FOOTER Genentech: Patients (https://gene.com/patients/)
Genentech: Patients
Breakthrough science. One moment, one day, one person at a time.
NAV_FOOTER Genentech: Our Medicines (https://gene.com/patients/medicines/)
Genentech: Our Medicines
Find important safety information and patient resources for all of our currently marketed medicines.
NAV_FOOTER Genentech: Patient Support Services (https://gene.com/patients/patient-support-services/)
Genentech: Patient Support Services
Breakthrough science. One moment, one day, one person at a time.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://gene.com) Genentech
[H2] Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.
SUB-PAGE · THIN (https://gene.com/patients/) Genentech: Patients
[H2] Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.
SUB-PAGE (https://gene.com/patients/medicines/) Genentech: Our Medicines
Patients / Our Medicines [H1] Our Medicines & Products Medicines Actemra® (tocilizumab) [IMG: Actemra] Activase® (alteplase) [IMG: Activase] Alecensa® (alectinib) [IMG: Alecensa] Avastin® (bevacizumab) [IMG: Avastin] Cathflo Activase® (alteplase) [IMG: Cathflo Activase] CellCept® (mycophenolate mofetil) [IMG: CellCept] Columvi® (glofitamab-gxbm) [IMG: Columvi] Cotellic® (cobimetinib) [IMG: Cotellic] Enspryng® (satralizumab-mwge) [IMG: Enspryng] Erivedge® (vismodegib) [IMG: Erivedge] Esbriet® (pirfenidone) [IMG: Esbriet] Evrysdi® (risdiplam) [IMG: Evrysdi] Gazyva® (obinutuzumab) [IMG: Gazyva] Hemlibra® (emicizumab-kxwh) [IMG: Hemlibra] Herceptin® (trastuzumab) [IMG: Herceptin] Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk) [IMG: Herceptin Hylecta] Itovebi™ (inavolisib) [IMG: Itovebi] Kadcyla® (ado-trastuzumab emtansine) [IMG: Kadcyla] Lucentis® (ranibizumab injection) [IMG: Lucentis] Lunsumio® (mosunetuzumab-axgb) [IMG: Lunsumio] Lunsumio Velo™ (mosunetuzumab-axgb) Luxturna® (voretigene neparvovec-rzyl) [IMG: Luxturna] Nutropin AQ® ((somatropin) injection for subcutaneous use) [IMG: Nutropin AQ] Ocrevus® (ocrelizumab) [IMG: Ocrevus] Ocrevus Zunovo® (ocrelizumab and hyaluronidase-ocsq) [IMG: Ocrevus Zunovo] Perjeta® (pertuzumab) [IMG: Perjeta] Phesgo® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) [IMG: Phesgo] PiaSky® (crovalimab-akkz) [IMG: PiaSky] Polivy® (polatuzumab vedotin-piiq) [IMG: Polivy] Pulmozyme® (dornase alfa) [IMG: Pulmozyme] Rituxan® (rituximab [Oncology]) [IMG: Rituxan] Rituxan® (rituximab [Immunology]) [IMG: Rituxan] Rituxan Hycela® (rituximab and hyaluronidase human) [IMG: Rituxan Hycela] Rozlytrek® (entrectinib) [IMG: Rozlytrek] Susvimo® (ranibizumab injection) [IMG: Susvimo] Tamiflu® (oseltamivir phosphate) [IMG: Tamiflu] Tecentriq® (atezolizumab) [IMG: Tecentriq] Tecentriq Hybreza™ (atezolizumab and hyaluronidase-tqjs) [IMG: Tecentriq Hybreza] TNKase® (tenecteplase) [IMG: TNKase] Vabysmo® (faricimab-svoa) [IMG: Vabysmo] Venclexta® (venetoclax) [IMG: Venclexta] Xofluza® (baloxavir marboxil) [IMG: Xofluza] Xolair® (omalizumab) [IMG: Xolair] Zelboraf® (vemurafenib) [IMG: Zelboraf] [H2] You Might Also Be Interested In [H3] Patient Resource Center Our patient resource center is dedicated to getting patients and caregivers to the right resources. 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST [H3] Report a side effect You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555 or here. Medicine Information SupportAsk about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call a nurse By calling (800) 821-8590Monday-Friday, 5am-5pm PT. Chat with a nurse Use our online chat feature Monday-Friday, 5am-5pm PT. Email a nurse By filling out this form. Sharps Disposal A guide for dealing with used sharps responsibly. Access to Investigational Medicines We're committed to a fair and impartial evaluation of each request for access to our investigational medicines. Find Open Clinical Trials Search clinicaltrials.gov to find out if a trial exists for a specific medicine for a particular disease. [H1] Access to Medicines Genentech Access Solutions offers coverage support, patient assistance, other useful information.
SUB-PAGE (https://gene.com/patients/patient-support-services/) Genentech: Patient Support Services
Patients / Patient Support Services [H5] If you have health insurance and need help paying for your medicine Find affordability options to help you pay for your Genentech medicine. Financial assistance may be available no matter what type of health insurance you have. Learn more [H5] If you don’t have health insurance coverage or have financial concerns and meet eligibility criteria Learn how the Genentech Patient Foundation may be able to help you get your Genentech medicine at no cost. Learn more [H5] If you need help understanding your health insurance coverage and costs Genentech Access Solutions helps people who are taking a Genentech medicine. We work with your doctor’s office, health insurance plan and/or specialty pharmacy to help you get your medicine. Call (877) GENENTECH/(877) 436-3683 to learn more. [H5] If you want information and resources about a health condition and treatment with a Genentech medicine Receive in-person education, mail for updates and tips about your medicine and answers to your questions about your treatment with Genentech Patient Education and Treatment Resources.* Call (877) GENENTECH/(877) 436-3683 to learn more. *Not all of these programs may be available for your specific medicine. [H3] Caregiver Burnout Brochure Gives an overview about burnout, including what it is, common symptoms, how to identify and prevent it and available resources. Download the brochure: English | Spanish [H1] Enroll in Patient Support Services Learn how to complete the Patient Consent Form. [H1] Understanding Insurance & Coverage Get help understanding your health insurance and learn about what options for coverage are out there.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 11 | 1 |
| /patients/ | 2 | 1 |
| /patients/medicines/ | 2 | 1 |
| /patients/patient-support-services/ | 2 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Genentech has 14.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Genentech (gene.com)
Genentech is a high-substance entity using a slightly dated and cliché-heavy corporate wrapper. While the marketing language is generic, the underlying data regarding its medicine portfolio and patient access programs is concrete and verifiable. The lack of structured data is the only significant red flag in an otherwise authoritative digital presence.
First, implement comprehensive Organization and MedicalOrganization JSON-LD schema to bridge the authority gap in structured data. Second, replace the generic ‘Breakthrough science’ meta-titles with specific therapeutic milestones or recent FDA approval counts to increase information density. Third, name the specific clinical leads or department heads within the support resources to move away from anonymous ‘nurse’ claims. Finally, update the site’s technical headers to remove legacy IE10 warnings that undermine the brand’s scientific leadership positioning.
The site perfectly aligns with the Pharma & Biotech industry category. The content is heavily focused on therapeutic areas, FDA reporting mechanisms, and a massive index of proprietary medicines such as Actemra, Avastin, and Ocrevus.
“The score of 26 is driven primarily by the high technical and identity gaps (Pillar 5) and the use of industry-standard cliches (Pillar 4). The site scores very well in Information Density and Semantic Coherence because it provides an extensive list of real-world products and specific contact information. The total absence of schema for a company of this size accounts for nearly 20% of the total BS score.”
This training module utilizes a snapshot of public data from Genentech, captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Genentech: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://gene.com to view the most current version of its content and learn from the source what this company is about and what it offers.